Atto Bioscience Overview
- Year Founded
-
1985
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$25.8M
Atto Bioscience General Information
Description
Developer of novel technologies for investigating biochemical and physiological changes in living cells in real time. The company develops, manufactures and markets products enabling real-time kinetic and structural analysis of biological reactions taking place in individual living cells.
Contact Information
Corporate Office
- 15010 Broschart Road
- Rockville, MD 20850
- United States
Corporate Office
- 15010 Broschart Road
- Rockville, MD 20850
- United States
Atto Bioscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 01-Jul-2004 | $25.8M | Completed | Generating Revenue | ||
| 2. Grant | Completed | Generating Revenue | ||||
| 1. Later Stage VC (Series A) | 29-Oct-2001 | $3M | $3M | Completed | Generating Revenue |
Atto Bioscience Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Atto Bioscience Patents
Atto Bioscience Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-1723573-A2 | Interpolated image response | Inactive | 28-Jan-2004 | ||
| EP-1682577-B1 | Cell-based assays employing voltage and calcium dyes | Inactive | 30-Oct-2003 | ||
| EP-1682577-A2 | Novel cell-based assays employing voltage and calcium dyes | Active | 30-Oct-2003 | ||
| EP-1682577-A4 | Novel cell-based assays employing voltage and calcium dyes | Active | 30-Oct-2003 | ||
| US-20040110244-A1 | Between a drug-sensitive and drug-resistant cell by measuring the comparative decay rates of a cellular ion | Active | 06-Dec-2002 | G01N33/5011 |
Atto Bioscience Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Defense Advanced Research Projects Agency | Government | |||
| Emerging Technology Partners (Venture Capital) | Venture Capital | Minority |
Atto Bioscience FAQs
-
When was Atto Bioscience founded?
Atto Bioscience was founded in 1985.
-
Where is Atto Bioscience headquartered?
Atto Bioscience is headquartered in Rockville, MD.
-
What industry is Atto Bioscience in?
Atto Bioscience’s primary industry is Biotechnology.
-
Is Atto Bioscience a private or public company?
Atto Bioscience is a Private company.
-
What is the current valuation of Atto Bioscience?
The current valuation of Atto Bioscience is .
-
What is Atto Bioscience’s current revenue?
The current revenue for Atto Bioscience is .
-
How much funding has Atto Bioscience raised over time?
Atto Bioscience has raised $3M.
-
Who are Atto Bioscience’s investors?
Defense Advanced Research Projects Agency and Emerging Technology Partners (Venture Capital) have invested in Atto Bioscience.
-
When was Atto Bioscience acquired?
Atto Bioscience was acquired on 01-Jul-2004.
-
Who acquired Atto Bioscience?
Atto Bioscience was acquired by Becton, Dickinson and Company.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
